Disclose
发表于 2025-3-21 16:19:47
书目名称Suffrage and Its Legacy in the Nordics and Beyond影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0881623<br><br> <br><br>书目名称Suffrage and Its Legacy in the Nordics and Beyond影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0881623<br><br> <br><br>书目名称Suffrage and Its Legacy in the Nordics and Beyond网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0881623<br><br> <br><br>书目名称Suffrage and Its Legacy in the Nordics and Beyond网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0881623<br><br> <br><br>书目名称Suffrage and Its Legacy in the Nordics and Beyond被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0881623<br><br> <br><br>书目名称Suffrage and Its Legacy in the Nordics and Beyond被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0881623<br><br> <br><br>书目名称Suffrage and Its Legacy in the Nordics and Beyond年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0881623<br><br> <br><br>书目名称Suffrage and Its Legacy in the Nordics and Beyond年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0881623<br><br> <br><br>书目名称Suffrage and Its Legacy in the Nordics and Beyond读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0881623<br><br> <br><br>书目名称Suffrage and Its Legacy in the Nordics and Beyond读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0881623<br><br> <br><br>
PANIC
发表于 2025-3-22 00:04:43
http://reply.papertrans.cn/89/8817/881623/881623_2.png
沉默
发表于 2025-3-22 01:28:05
Josefina Erikson,Lenita Freidenvalls have topped US$ 33 billion in 2003 compared to around US$ 13 billion just a decade ago. At the same time, the number of new drug approvals has dropped from 53 in 1996 to only 35 in 2003. Moreover, the protraction of clinical trials has significantly reduced the effective time of patent protection.
commensurate
发表于 2025-3-22 05:50:26
s have topped US$ 33 billion in 2003 compared to around US$ 13 billion just a decade ago. At the same time, the number of new drug approvals has dropped from 53 in 1996 to only 35 in 2003. Moreover, the protraction of clinical trials has significantly reduced the effective time of patent protection.
Harass
发表于 2025-3-22 11:21:06
Pål Brunnström,Magnus Olofssonped US$ 33 billion in 2003 compared to around US$ 13 billion just a decade ago. At the same time, the number of new drug approvals has dropped from 53 in 1996 to only 35 in 2003. Moreover, the protraction of clinical trials has significantly reduced the effective time of patent protection. The conse
BLAND
发表于 2025-3-22 15:07:03
http://reply.papertrans.cn/89/8817/881623/881623_6.png
爵士乐
发表于 2025-3-22 17:30:59
http://reply.papertrans.cn/89/8817/881623/881623_7.png
管理员
发表于 2025-3-22 23:19:19
s of the Food and Drug Administration to discuss important clinical research issues. The Ninth Annual symposium on New Drugs addressed the problem of determining the risk versus benefit for use of three important classes of cardiovascular agents: thrombolytic, antiarrhythmic, and hypolipidemic agent
易受刺激
发表于 2025-3-23 02:09:21
http://reply.papertrans.cn/89/8817/881623/881623_9.png
Pituitary-Gland
发表于 2025-3-23 05:50:21
http://reply.papertrans.cn/89/8817/881623/881623_10.png